Condition
mCRPC or Advanced/Metastatic Solid Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 2 mCRPC or Advanced/Metastatic Solid Tumors clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
FX-111 safety and pharmacokinetics in metastatic castration-resistant prostate cancer
This study tests whether FX-111 is safe and can help treat metastatic castration-resistant prostate cancer in adult men.
-
HLX3902 first-in-human study in mCRPC and advanced solid tumors
This early, open-label study tests HLX3902 in adults with metastatic castration-resistant prostate cancer or other advanced solid tumors to see if it is safe and how it behaves in the body.
Related topics
Quick answers
How many mCRPC or Advanced/Metastatic Solid Tumors clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.